Obstructive hypertrophic cardiomyopathy: a review of new therapies.
Future cardiology • Vol. 19, Issue 13 • 2023
Aficamten: A Breakthrough Therapy for Symptomatic Obstructive Hypertrophic Cardiomyopathy.
American journal of cardiovascular drugs : drugs, devices, and other interventions • Vol. 23, Issue 5 • 2023
Discovery of Aficamten (CK-274), a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy.
Journal of medicinal chemistry • Vol. 64, Issue 19 • 2021
Emerging Medical Treatment for Hypertrophic Cardiomyopathy.
Journal of clinical medicine • Vol. 10, Issue 5 • 2021